Complicated skin infection from Enterobacter cloacae bacteria

A complicated skin infection from *Enterobacter cloacae* bacteria is a severe soft tissue infection involving deep dermal, subcutaneous, fascial, or muscular layers, frequently presenting as deep surgical site infections, major abscesses, or infected chronic ulcers

A complicated skin infection from *Enterobacter cloacae* bacteria is a severe soft tissue infection involving deep dermal, subcutaneous, fascial, or muscular layers, frequently presenting as deep surgical site infections, major abscesses, or infected chronic ulcers

A complicated skin infection from *Enterobacter cloacae* bacteria is a severe soft tissue infection involving deep dermal, subcutaneous, fascial, or muscular layers, frequently presenting as deep surgical site infections, major abscesses, or infected chronic ulcers Primarily affecting hospitalized, post-surgical, or immunocompromised individuals with impaired cutaneous barriers, this condition arises when this opportunistic, Gram-negative enteric bacillus invades vulnerable tissue Management typ...

Primarily affecting hospitalized, post-surgical, or immunocompromised individuals with impaired cutaneous barriers, this condition arises when this opportunistic, Gram-negative enteric bacillus invades vulnerable tissue Pathophysiologically, the organism triggers intense local inflammation, tissue necrosis, and potential systemic toxicity, often compounded by intrinsic or inducible AmpC beta-lactamase production that promotes resistance to standard broad-spectrum therapies

Primarily affecting hospitalized, post-surgical, or immunocompromised individuals with impaired cutaneous barriers, this condition arises when this opportunistic, Gram-negative enteric bacillus invades vulnerable tissue Management typically necessitates surgical intervention such as debridement alongside targeted parenteral antimicrobial therapy to prevent local destruction and hematogenous dissemination

Pathophysiologically, the organism triggers intense local inflammation, tissue necrosis, and potential systemic toxicity, often compounded by intrinsic or inducible AmpC beta-lactamase production that promotes resistance to standard broad-spectrum therapies

Pathophysiologically, the organism triggers intense local inflammation, tissue necrosis, and potential systemic toxicity, often compounded by intrinsic or inducible AmpC beta-lactamase production that promotes resistance to standard broad-spectrum therapies